Post-cycle therapy (PCT) explained
Updated 2026-04-30 · Reviewed by the DeusPowershop editorial team
Post-cycle therapy is the protocol an athlete runs after a cycle of anabolic-androgenic steroids or suppressive SARMs to restart endogenous testosterone production. It is the single most important determinant of long-term endocrine health for anyone who uses these compounds. For background see the post-cycle therapy article on Wikipedia and the 2015 review of anabolic-steroid-induced hypogonadism (PMC4744102).
What suppression actually means
The hypothalamus releases gonadotropin-releasing hormone (GnRH) in pulses. GnRH triggers the pituitary to release LH and FSH. LH stimulates Leydig cells in the testes to make testosterone; FSH supports spermatogenesis. Exogenous androgens — and to a lesser extent SARMs — feed back negatively on the hypothalamus, shutting off GnRH. Within a few weeks LH and FSH are at the floor and endogenous testosterone production stops.
The four classes of PCT drug
- SERMs (Selective Estrogen Receptor Modulators): Clomid (clomifene) and Nolvadex (tamoxifen). Block estrogenic negative feedback at the hypothalamus → LH and FSH rise → testes restart.
- hCG (human chorionic gonadotropin): mimics LH, stimulating the Leydig cells directly. Used during long cycles or just before SERM-PCT to restore testicular volume; not run alongside SERMs in classical protocols.
- AIs (Aromatase Inhibitors): anastrozole, exemestane. Lower estradiol when it is over-converting on cycle. Not a PCT drug — running an AI through PCT crashes estradiol and stalls recovery.
- Enclomiphene: the trans-isomer of clomifene with fewer mood/vision side effects. Increasingly used as a Clomid alternative.
A standard 4-week SERM PCT
Start once active compound has cleared (see the timing FAQ above). The most-published protocol:
| Week | Clomid | Nolvadex |
|---|---|---|
| 1 | 50 mg/day | 40 mg/day |
| 2 | 50 mg/day | 40 mg/day |
| 3 | 25 mg/day | 20 mg/day |
| 4 | 25 mg/day | 20 mg/day |
For lighter SARM-only cycles a single SERM at half these doses for 4 weeks is usually enough. For long or harsh cycles, hCG 250–500 IU twice weekly for 2–4 weeks before SERM-PCT helps restore Leydig-cell sensitivity.
Bloodwork is not optional
The only honest way to confirm a PCT worked is comparative bloodwork. A minimal panel:
- Pre-cycle baseline: total testosterone, free testosterone, LH, FSH, estradiol (sensitive assay), SHBG, prolactin, full lipids, hematocrit, ALT/AST.
- End-of-cycle: the same panel, to document where suppression and lipids landed.
- 4–6 weeks post-PCT: the same panel again. Total testosterone should be back inside its pre-cycle range and LH/FSH should be detectable.
What goes wrong
- PCT started too early: SERMs fight a still-present androgen. Wait the half-life-based clearance window.
- AI run through PCT: crashes estradiol, suppresses libido, stalls IGF-1 and frequently delays recovery.
- Skipping bloodwork: "I feel fine" is not a recovery signal. Free testosterone in the bottom decile of the reference range is not fine.
- Stacking back-to-back cycles: the longer the suppression, the lower the chance of full recovery. Allow at least cycle-length-equal time off.
Where to go next
- Browse the oral steroids and injectable steroids categories — every product page links to its compound profile.
- Read TUDCA and on-cycle liver support if your cycle includes 17α-alkylated orals.
- Compare SARMs vs anabolic steroids if you are deciding between the two routes.
Sources
- Rahnema et al., 2014 — Anabolic-androgenic steroid-induced hypogonadism (PMC4744102)
- Tan & Scally, 2009 — Restoration of HPGA after AAS use (PubMed 26609282)
- WADA prohibited list — SERMs & aromatase inhibitors (S4)
- Examine.com overview of SARMs and PCT
- Cleveland Clinic article on testosterone deficiency
- Healthline guide to post-cycle therapy